Applied Nanotech to Manufacture Nano-Copper Inks and Pastes

Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that it has entered into an exclusive worldwide license agreement with a leading industrial chemical products company in Japan for manufacturing and commercializing nano-copper inks and pastes.

Applied Nanotech will receive an upfront payment of $1.5 million, of which $500,000 is payable immediately, and $1.0 million is payable in June 2010. In addition, Applied Nanotech will receive a royalty of 4% of sales of the copper inks and pastes by its partner. The parties are also beginning discussions for a new research and development contract beginning October 1, 2009 to transition to the fourth phase of the project, which began in 2006.

"This is a giant step toward implementing our Technical Inks Printing Solution ('TIPS') strategy based on five important modules: nanoparticles manufacturing, inks development and manufacturing, technical printing applications development, processing development, and adequate hardware. Securing a trusted, high quality technology partner with a broad base of products used in electronic applications plays a vital role in our approach," said Dr. ZviYaniv, Chief Executive Officer of Applied Nanotech, Inc.

"We are pleased to have reached this milestone," said Doug Baker, CEO of APNT. "We look forward to a long and beneficial relationship with our partner in this area and the opportunities that this relationship provides."

Dr. Robert Ronstadt, Chairman of APNT, added, "I believe we will look back on this license, which provides strong support for the viability of our business model, as a seminal event in our company's history."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.